Qingdao Haier Biomedical Co.,Ltd (SHA:688139)

SHA:688139 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	901.23	1,269	951.78	774.39	1,849
Trading Asset Securities	877.25	651.14	2,024	2,130	408.03
Cash & Short-Term Investments	1,778	1,920	2,975	2,904	2,257
Cash Growth	-7.39%	-35.46%	2.45%	28.69%	-0.54%
Accounts Receivable	352.76	208.35	192.17	136.29	182.61
Other Receivables	8.56	7.47	3.99	32	20.38
Receivables	361.32	215.82	196.16	168.29	202.98
Inventory	334.74	248.02	270.55	345.75	247.95
Prepaid Expenses	0.14	2.56	1.21	0.41	0.97
Other Current Assets	177.77	149.21	45.19	38.23	25.36
Total Current Assets	2,652	2,536	3,489	3,457	2,734
Property, Plant & Equipment	915.18	862.22	802.08	464.13	343.6
Long-Term Investments	972.71	1,030	371.85	358.34	261.19
Goodwill	757.87	642.68	451.3	323.45	323.85
Other Intangible Assets	402.3	367.73	312.35	241.62	214.6
Long-Term Deferred Tax Assets	66.01	51.67	30.52	35.43	47.23
Long-Term Deferred Charges	6.72	5.69	5.46	0.5	1.27
Other Long-Term Assets	14.24	29.18	26.91	19.53	16.89
Total Assets	5,787	5,526	5,489	4,900	3,943
Accounts Payable	427.6	390.98	485.06	431.57	448.09
Accrued Expenses	228.65	235.15	245.6	196.05	184.35
Short-Term Debt	10.01	6.01	10.01	-	25
Current Portion of Leases	5.76	3.42	5.48	1.65	-
Current Income Taxes Payable	35.21	35.8	28.68	48.01	40.3
Current Unearned Revenue	151.98	111.81	232.84	362.05	247.82
Other Current Liabilities	163.2	158.51	176.81	104.17	98.8
Total Current Liabilities	1,022	941.66	1,184	1,144	1,044
Long-Term Leases	7.43	8.69	10.67	4.32	-
Long-Term Unearned Revenue	23.17	28.62	32.88	32.18	32.65
Long-Term Deferred Tax Liabilities	52.51	46.99	43.59	25.9	29.43
Other Long-Term Liabilities	63.81	59.75	69.03	55.18	51.65
Total Liabilities	1,169	1,086	1,341	1,261	1,158
Common Stock	317.95	317.95	317.95	317.07	317.07
Additional Paid-In Capital	1,977	1,987	1,995	1,913	1,876
Retained Earnings	2,219	2,015	1,751	1,309	584.29
Treasury Stock	-140.2	-99.74	-98.07	-	-
Comprehensive Income & Other	-2.69	10.37	53.89	84.34	-1.01
Total Common Equity	4,372	4,231	4,021	3,623	2,776
Minority Interest	246.59	209.25	127.71	15.95	8.64
Shareholders' Equity	4,618	4,440	4,148	3,639	2,785
Total Liabilities & Equity	5,787	5,526	5,489	4,900	3,943
Total Debt	23.2	18.11	26.15	5.97	25
Net Cash (Debt)	1,755	1,902	2,949	2,898	2,232
Net Cash Growth	-7.73%	-35.50%	1.76%	29.86%	-1.64%
Net Cash Per Share	5.55	6.00	9.28	9.12	6.85
Filing Date Shares Outstanding	314.48	315.68	316.49	317.07	317.07
Total Common Shares Outstanding	314.48	316.47	316.49	317.07	317.07
Working Capital	1,630	1,594	2,304	2,313	1,690
Book Value Per Share	13.90	13.37	12.70	11.43	8.75
Tangible Book Value	3,211	3,220	3,257	3,058	2,237
Tangible Book Value Per Share	10.21	10.18	10.29	9.64	7.06
Buildings	696.63	649.88	257.73	243.72	230.31
Machinery	333.52	284.75	240.79	151.04	122.68
Construction In Progress	95.03	70.33	389.34	130.96	32.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.